DK317678A - Fremgangsmaade til fremstilling af 3-(1-pyrazolyl)-pyridazindf erivater eller farmaceutisk acceptable syreaddtionssalte dera - Google Patents

Fremgangsmaade til fremstilling af 3-(1-pyrazolyl)-pyridazindf erivater eller farmaceutisk acceptable syreaddtionssalte dera

Info

Publication number
DK317678A
DK317678A DK317678A DK317678A DK317678A DK 317678 A DK317678 A DK 317678A DK 317678 A DK317678 A DK 317678A DK 317678 A DK317678 A DK 317678A DK 317678 A DK317678 A DK 317678A
Authority
DK
Denmark
Prior art keywords
pyridazindf
erivates
pyrazolyl
procedure
preparation
Prior art date
Application number
DK317678A
Other languages
Danish (da)
English (en)
Inventor
G Szilagyi
E Kasztreiner
L Tardos
E Kosa
L Jazlits
G Cseh
I Kovacs
P Tolnay
S Elek
I Elekes
I Polgari
Original Assignee
Richter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter filed Critical Richter
Publication of DK317678A publication Critical patent/DK317678A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK317678A 1977-10-25 1978-07-14 Fremgangsmaade til fremstilling af 3-(1-pyrazolyl)-pyridazindf erivater eller farmaceutisk acceptable syreaddtionssalte dera DK317678A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77GO1381A HU176100B (en) 1977-10-25 1977-10-25 Process for preparing new 3-/1-pyrazolyl/-pyridazine derivatives

Publications (1)

Publication Number Publication Date
DK317678A true DK317678A (da) 1979-04-26

Family

ID=10996838

Family Applications (1)

Application Number Title Priority Date Filing Date
DK317678A DK317678A (da) 1977-10-25 1978-07-14 Fremgangsmaade til fremstilling af 3-(1-pyrazolyl)-pyridazindf erivater eller farmaceutisk acceptable syreaddtionssalte dera

Country Status (24)

Country Link
US (1) US4224325A (de)
JP (1) JPS5461187A (de)
AT (1) AT359076B (de)
AU (1) AU525814B2 (de)
BE (1) BE868987A (de)
CA (1) CA1090337A (de)
CH (1) CH637951A5 (de)
CS (1) CS217964B2 (de)
DD (1) DD139848A5 (de)
DE (1) DE2831072A1 (de)
DK (1) DK317678A (de)
ES (1) ES471779A1 (de)
FI (1) FI63397C (de)
FR (1) FR2407211A1 (de)
GB (1) GB2007644B (de)
HU (1) HU176100B (de)
IL (1) IL55120A (de)
IT (1) IT1097156B (de)
NL (1) NL7807572A (de)
NO (1) NO149354C (de)
PL (2) PL118799B1 (de)
SE (1) SE437988B (de)
SU (3) SU847920A3 (de)
YU (1) YU169878A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302457A (en) * 1977-04-13 1981-11-24 The Upjohn Company Process for therapeutic treatment
US4302456A (en) * 1977-04-13 1981-11-24 The Upjohn Company Process for therapeutic treatment
DE2935359A1 (de) * 1979-09-01 1981-03-26 Basf Ag, 67063 Ludwigshafen 6-imidazolyl-3-hydrazino-pyridazine
US4304775A (en) * 1979-12-13 1981-12-08 Sterling Drug Inc. 3-Hydrazino-6-(pyridinyl) pyridazines and cardiotonic use thereof
US4503056A (en) * 1982-03-02 1985-03-05 Abbott Laboratories 1-(Pyridazinyl)pyrazoline derivatives
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1220428B (de) 1960-03-25 1966-07-07 Takeda Pharmaceutical Verfahren zur Herstellung von 2-Pyrazolyl-(1')-pyrimidinderivaten und deren Salzen
JPS5831347B2 (ja) * 1975-09-05 1983-07-05 中外製薬株式会社 ピラゾリルピリダジンユウドウタイノ セイホウ
HU175471B (hu) * 1977-06-13 1980-08-28 Gyogyszerkutato Intezet Sposob poluchenija novykh proizvodnykh 3-skobka-1-pirazolil-skobka zakryta-piridazina

Also Published As

Publication number Publication date
SU847920A3 (ru) 1981-07-15
IT7825681A0 (it) 1978-07-14
NO782446L (no) 1979-04-26
CH637951A5 (de) 1983-08-31
AU525814B2 (en) 1982-12-02
FI63397B (fi) 1983-02-28
FR2407211A1 (fr) 1979-05-25
GB2007644B (en) 1982-03-10
YU169878A (en) 1983-01-21
SE7807822L (sv) 1979-04-26
FI782237A (fi) 1979-04-26
AT359076B (de) 1980-10-27
DD139848A5 (de) 1980-01-23
GB2007644A (en) 1979-05-23
FI63397C (fi) 1983-06-10
NO149354B (no) 1983-12-27
SU845786A3 (ru) 1981-07-07
NO149354C (no) 1984-04-04
IT1097156B (it) 1985-08-26
HU176100B (en) 1980-12-28
AU3799778A (en) 1980-01-17
ATA509278A (de) 1980-03-15
PL115063B1 (en) 1981-03-31
CS217964B2 (en) 1983-02-25
PL118799B1 (en) 1981-10-31
BE868987A (fr) 1979-01-15
CA1090337A (en) 1980-11-25
ES471779A1 (es) 1979-10-01
NL7807572A (nl) 1979-04-27
JPS5527063B2 (de) 1980-07-17
SU856385A3 (ru) 1981-08-15
FR2407211B1 (de) 1982-09-03
SE437988B (sv) 1985-03-25
IL55120A0 (en) 1978-09-29
JPS5461187A (en) 1979-05-17
DE2831072A1 (de) 1979-05-10
IL55120A (en) 1982-05-31
US4224325A (en) 1980-09-23
PL208409A1 (de) 1980-02-25
PL218031A1 (de) 1980-07-14

Similar Documents

Publication Publication Date Title
DK149895C (da) Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK56077A (da) Fremgangsmade til fremstilling af 3-quinolincarboxylsyrederivater eller additionssalte deraf
DK178379A (da) Fremgangsmaade til fremstilling af n-substituerede moranolinderivater eller syreadditionssalte deraf
DK151884C (da) Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK148478A (da) Fremgangsmaade til fremstilling af cycloalkansubstituerede phenyleddikesyrederivater eller farmaceutisk acceptable salte eller estere deraf
DK15279A (da) Fremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK392877A (da) Fremgangsmaade til fremstilling af phenylethylaminer eller syreadditionssalte heraf
DK345778A (da) Fremgangsmaade til fremstilling af 4-substituerede pyrazoler eller syreadditionssalte deraf
DK323780A (da) Fremgangsmaade til fremstilling af substituerede 3-amino-sydnonimider eller farmakologisk acceptable syreadditionssalte deraf
DK392578A (da) Fremgangsmaade til fremstilling af 2-substituerede 5-hydroxy-1h-imidazol-4-carboxamidderivater eller farmaceutisk acceptble salte deraf
DK154950C (da) Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf
DK335279A (da) Fremgangsmaade til fremstilling af spirofuranohydantoin-forbindelser eller farmaceutisk acceptable metalsalte deraf
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK159079A (da) Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf
DK142544C (da) Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK338376A (da) Fremgangsmade til fremstilling af aminobenzocycloheptenderivater eller additionssalte deraf
DK386876A (da) Fremgangsmade til fremstilling af n-tetrahydrofurfuryl-noroxymorphoner eller syreadditionssalte deraf
DK58677A (da) Fremgangsmade til fremstilling af m-trifluormethylphenylpiperidinderivater eller additionssalte deraf
DK152208C (da) Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf
DK317678A (da) Fremgangsmaade til fremstilling af 3-(1-pyrazolyl)-pyridazindf erivater eller farmaceutisk acceptable syreaddtionssalte dera
DK152427C (da) Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK491678A (da) Fremgangsmaade til fremstilling af arylaetere af n-alkylpiperidiner eller syreadditionssalte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment